Cel-Sci
CVM
#10616
Rank
NZ$34.49 M
Marketcap
NZ$1.97
Share price
-4.92%
Change (1 day)
-87.64%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$14.48 Million

According to Cel-Sci 's latest financial reports the company's total debt is NZ$14.48 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-09-30NZ$16.19 M-11.6%
2024-09-30NZ$18.31 M-19.09%
2023-09-30NZ$22.63 M-16.61%
2022-09-30NZ$27.14 M17.23%
2021-09-30NZ$23.15 M10.05%
2020-09-30NZ$21.04 M-2.44%
2019-09-30NZ$21.57 M6.78%
2018-09-30NZ$20.2 M2.26%
2017-09-30NZ$19.75 M10.22%
2016-09-30NZ$17.92 M-17.55%
2015-09-30NZ$21.73 M1413.37%
2014-09-30NZ$1.43 M5.14%
2013-09-30NZ$1.36 M2.43%
2012-09-30NZ$1.33 M-79.52%
2011-09-30NZ$6.51 M332.88%
2010-09-30NZ$1.5 M-3.03%
2009-09-30NZ$1.55 M422.46%
2008-09-30NZ$0.29 M
2005-09-30NZ$0 M-2.74%
2004-09-30NZ$0 M-99.7%
2003-09-30NZ$1.47 M-60.81%
2002-09-30NZ$3.76 M4811.62%
2001-09-30NZ$0.07 M25.57%
2000-09-30NZ$0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$93.56 B 645,876.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$97.53 B 673,319.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.29 B 1,957.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ$2.27 M-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$28.76 B 198,520.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
NZ$1.39 B 9,506.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.97 B 6,638.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$0.66 M-95.43%๐Ÿ‡บ๐Ÿ‡ธ USA